期刊文献+

参苓白术辅助治疗对老年溃疡性结肠炎伴脓血便患者临床疗效及免疫功能的影响 被引量:3

Influence of Adjunctive Therapy with Shenling Baizhu Powder on the Immune Function and Clinical Effect of Elderly Patients with Colitis Gravis and Bloody Purulent Stool
原文传递
导出
摘要 目的:探讨参苓白术辅助治疗对老年溃疡性结肠炎伴脓血便患者临床疗效及免疫功能的影响。方法:选取于我院进行治疗的老年溃疡性结肠炎伴脓血便患者50例,随机分为实验组与对照组,每组25例。对照组患者给予柳氮磺吡啶结肠溶胶囊进行治疗,实验组患者在对照组的基础上联合使用参苓白术丸进行治疗,两组患者均治疗3个月,比较两组患者治疗前后血清白介素-2(IL-2)、γ-干扰素(IFN-γ)及白介素-10(IL-10)水平,并评价两组患者的临床疗效。结果:与治疗前相比,两组患者治疗后的血清IL-2、IFN-γ水平均显著降低,IL-10明显升高;与对照组相比,实验组患者血清IL-2、IFN-γ水平较低,IL-10水平更高(P<0.05);且与对照组相比,实验组患者的临床总有效率较高(P<0.05)。结论:参苓白术散能有效改善老年溃疡性结肠炎伴脓血便患者的免疫功能并提高其临床疗效。 Objective:To investigate the influence of shenling baizhu powder on the immune function and clinical effect of elderly patients with colitis gravis and bloody purulent stool.Methods:50 elderly patients with colitis gravis and bloody purulent stool who were treated in our hospital were selected and randomly divided into the experimental group and control group with 25 cases in each group,patients in the control group were treated with sulfasalazine colonosoluble capsules,patients in the experimental group were treated on the base of the control group with shenling baizhu powder,patients in both groups of were treated for 3 months,the serum intedeukin 2 (IL-2),γ-interferon (IFN-γ) and interleukin 10 (IL-10) levels of both groups were compared before and after treatment,and the clinical efficacy of the two groups of patients were evaluated.Results:Compared with before treatment,the serum IL-2,IFN-γ IL-10 levels of both groups were obviously decreased after treatment;compared with the control group,the serum IL-2,IFN-γ and IL-10 levels of experimental group were significantly lower (P〈0.05);and compared with the control group,the total clinical effective rote of experimental group was higher (P〈0.05).Conclusion:Shenling baizhu powder could effectively improve the immune function and clinical effect of elderly patients with colitis gravis and bloody purulent stool.
出处 《现代生物医学进展》 CAS 2017年第15期2920-2922,2906,共4页 Progress in Modern Biomedicine
基金 四川省卫生厅科研基金项目(130212)
关键词 参苓白术 老年溃疡性结肠炎 免疫功能 临床疗效 Shenling baizhu powder Elderly patients with colitis gravis Immune function Clinical efficacy
  • 相关文献

参考文献8

二级参考文献62

  • 1郑长春,于中麟,陈学清,姜泊.对"慢性胃炎的内镜分型分级标准及治疗的试行意见"的商榷[J].中华消化内镜杂志,2004,21(6):427-428. 被引量:565
  • 2姚堃,周家仪,吴文翰,陈国雄,陆颖思.不同期鼻咽癌病人血清中TNF-α和IFN-γ活性检测[J].上海免疫学杂志,1996,16(2):80-82. 被引量:11
  • 3吴长有.Th17细胞:一种新的效应CD4^+T细胞亚群[J].细胞与分子免疫学杂志,2006,22(6):695-697. 被引量:36
  • 4赵辨.中国临床皮肤病学[M].南京:江苏科学技术出版社,2009,12:744.
  • 5刘庆林,曾姣飞,李美珍,袁晓红,罗文辉.扶正抗癌合剂联合卡培他滨治疗31例晚期胃癌临床观察[J].中医药导报,2007,13(10):27-28. 被引量:3
  • 6Kavitha Subramaniam,James D’Rozario,Paul Pavli.Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review[J]. J Gastroenterol Hepatol . 2012 (1)
  • 7Mehmet Coskun,Mohammad Salem,Jannie Pedersen,Ole Haagen Nielsen.Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease[J].Pharmacological Research.2013
  • 8William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar J?rnerot,Paul Rutgeerts.Subcutaneous Golimumab Maintains Clinical Response in Patients with Moderate-To-Severe Ulcerative Colitis[J].Gastroenterology.2013
  • 9William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar J?rnerot,Toshifumi Hibi,Paul Rutgeerts.Subcutaneous Golimumab Induces Clinical Response and Remission in Patients with Moderate-To-Severe Ulcerative Colitis[J].Gastroenterology.2013
  • 10David Laharie,Arnaud Bourreille,Julien Branche,Matthieu Allez,Yoram Bouhnik,Jerome Filippi,Frank Zerbib,Guillaume Savoye,Maria Nachury,Jacques Moreau,Jean-Charles Delchier,Jacques Cosnes,Elena Ricart,Olivier Dewit,Antonio Lopez-Sanroman,Jean-Louis Dupas,Franck Carbonnel,Gilles Bommelaer,Benoit Coffin,Xavier Roblin,Gert Van Assche,Maria Esteve,Martti F?rkkil?,Javier P Gisbert,Philippe Marteau,Stephane Nahon,Martine de Vos,Denis Franchimont,Jean-Yves Mary,Jean-Frederic Colombel,Marc Lémann.Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial[J].The Lancet.2012(9857)

共引文献107

同被引文献40

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部